Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Refractory status epilepticus in children with and without prior epilepsy or status epilepticus.

Sánchez Fernández I, Jackson MC, Abend NS, Arya R, Brenton JN, Carpenter JL, Chapman KE, Gaillard WD, Gaínza-Lein M, Glauser TA, Goldstein JL, Goodkin HP, Helseth A, Kapur K, McDonough TL, Mikati MA, Peariso K, Riviello J Jr, Tasker RC, Topjian AA, Wainwright MS, Wilfong A, Williams K, Loddenkemper T; pediatric Status Epilepticus Research Group (pSERG)..

Neurology. 2017 Jan 24;88(4):386-394. doi: 10.1212/WNL.0000000000003550. Epub 2016 Dec 23.

PMID:
28011930
2.

Second monotherapy in childhood absence epilepsy.

Cnaan A, Shinnar S, Arya R, Adamson PC, Clark PO, Dlugos D, Hirtz DG, Masur D, Glauser TA; Childhood Absence Epilepsy Study Group..

Neurology. 2017 Jan 10;88(2):182-190. doi: 10.1212/WNL.0000000000003480. Epub 2016 Dec 16.

PMID:
27986874
3.

Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients.

Treat L, Chapman KE, Colborn KL, Knupp KG.

Epilepsia. 2017 Jan;58(1):123-127. doi: 10.1111/epi.13617. Epub 2016 Nov 18.

PMID:
27859038
4.

High-resolution crystal structure of the human CB1 cannabinoid receptor.

Shao Z, Yin J, Chapman K, Grzemska M, Clark L, Wang J, Rosenbaum DM.

Nature. 2016 Nov 16. doi: 10.1038/nature20613. [Epub ahead of print]

PMID:
27851727
5.

Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital.

Tasker RC, Goodkin HP, Sánchez Fernández I, Chapman KE, Abend NS, Arya R, Brenton JN, Carpenter JL, Gaillard WD, Glauser TA, Goldstein J, Helseth AR, Jackson MC, Kapur K, Mikati MA, Peariso K, Wainwright MS, Wilfong AA, Williams K, Loddenkemper T; Pediatric Status Epilepticus Research Group..

Pediatr Crit Care Med. 2016 Oct;17(10):968-975.

PMID:
27500721
6.

Obesity and overweight as CAE comorbidities and differential drug response modifiers.

Arya R, Gillespie CW, Cnaan A, Devarajan M, Clark P, Shinnar S, Vinks AA, Mizuno K, Glauser TA; Childhood Absence Epilepsy Study Group..

Neurology. 2016 Apr 26;86(17):1613-21. doi: 10.1212/WNL.0000000000002611. Epub 2016 Mar 30.

PMID:
27029636
7.

Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial.

Shinnar S, Cnaan A, Hu F, Clark P, Dlugos D, Hirtz DG, Masur D, Mizrahi EM, Moshé SL, Glauser TA; Childhood Absence Epilepsy Study Group..

Neurology. 2015 Sep 29;85(13):1108-14. doi: 10.1212/WNL.0000000000001971. Epub 2015 Aug 26.

8.

Seizing control of epileptic activity can improve outcome.

Chapman KE, Specchio N, Shinnar S, Holmes GL.

Epilepsia. 2015 Oct;56(10):1482-5. doi: 10.1111/epi.13109. Epub 2015 Aug 21. Review.

9.

Incidence of seizures on continuous EEG monitoring following traumatic brain injury in children.

O'Neill BR, Handler MH, Tong S, Chapman KE.

J Neurosurg Pediatr. 2015 Aug;16(2):167-76. doi: 10.3171/2014.12.PEDS14263. Epub 2015 May 8.

PMID:
25955809
10.

Time from convulsive status epilepticus onset to anticonvulsant administration in children.

Sánchez Fernández I, Abend NS, Agadi S, An S, Arya R, Brenton JN, Carpenter JL, Chapman KE, Gaillard WD, Glauser TA, Goodkin HP, Kapur K, Mikati MA, Peariso K, Ream M, Riviello J Jr, Tasker RC, Loddenkemper T; Pediatric Status Epilepticus Research Group (pSERG)..

Neurology. 2015 Jun 9;84(23):2304-11. doi: 10.1212/WNL.0000000000001673. Epub 2015 May 6.

11.

The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.

Kölker S, Garcia-Cazorla A, Valayannopoulos V, Lund AM, Burlina AB, Sykut-Cegielska J, Wijburg FA, Teles EL, Zeman J, Dionisi-Vici C, Barić I, Karall D, Augoustides-Savvopoulou P, Aksglaede L, Arnoux JB, Avram P, Baumgartner MR, Blasco-Alonso J, Chabrol B, Chakrapani A, Chapman K, I Saladelafont EC, Couce ML, de Meirleir L, Dobbelaere D, Dvorakova V, Furlan F, Gleich F, Gradowska W, Grünewald S, Jalan A, Häberle J, Haege G, Lachmann R, Laemmle A, Langereis E, de Lonlay P, Martinelli D, Matsumoto S, Mühlhausen C, de Baulny HO, Ortez C, Peña-Quintana L, Ramadža DP, Rodrigues E, Scholl-Bürgi S, Sokal E, Staufner C, Summar ML, Thompson N, Vara R, Pinera IV, Walter JH, Williams M, Burgard P.

J Inherit Metab Dis. 2015 Nov;38(6):1041-57. doi: 10.1007/s10545-015-9839-3. Epub 2015 Apr 15. Erratum in: J Inherit Metab Dis. 2015 Nov;38(6):1155-6. Cazorla, Angeles Garcia [corrected to Garcia-Cazorla, Angeles].

PMID:
25875215
12.

Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy.

Press CA, Knupp KG, Chapman KE.

Epilepsy Behav. 2015 Apr;45:49-52. doi: 10.1016/j.yebeh.2015.02.043. Epub 2015 Apr 3.

PMID:
25845492
13.

Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect.

Simons C, Griffin LB, Helman G, Golas G, Pizzino A, Bloom M, Murphy JL, Crawford J, Evans SH, Topper S, Whitehead MT, Schreiber JM, Chapman KA, Tifft C, Lu KB, Gamper H, Shigematsu M, Taft RJ, Antonellis A, Hou YM, Vanderver A.

Am J Hum Genet. 2015 Apr 2;96(4):675-81. doi: 10.1016/j.ajhg.2015.02.012. Epub 2015 Mar 26.

14.

Consensus statement on continuous EEG in critically ill adults and children, part I: indications.

Herman ST, Abend NS, Bleck TP, Chapman KE, Drislane FW, Emerson RG, Gerard EE, Hahn CD, Husain AM, Kaplan PW, LaRoche SM, Nuwer MR, Quigg M, Riviello JJ, Schmitt SE, Simmons LA, Tsuchida TN, Hirsch LJ; Critical Care Continuous EEG Task Force of the American Clinical Neurophysiology Society..

J Clin Neurophysiol. 2015 Apr;32(2):87-95. doi: 10.1097/WNP.0000000000000166.

15.

Consensus statement on continuous EEG in critically ill adults and children, part II: personnel, technical specifications, and clinical practice.

Herman ST, Abend NS, Bleck TP, Chapman KE, Drislane FW, Emerson RG, Gerard EE, Hahn CD, Husain AM, Kaplan PW, LaRoche SM, Nuwer MR, Quigg M, Riviello JJ, Schmitt SE, Simmons LA, Tsuchida TN, Hirsch LJ; Critical Care Continuous EEG Task Force of the American Clinical Neurophysiology Society..

J Clin Neurophysiol. 2015 Apr;32(2):96-108. doi: 10.1097/WNP.0000000000000165.

16.

Development and validation of a seizure prediction model in critically ill children.

Yang A, Arndt DH, Berg RA, Carpenter JL, Chapman KE, Dlugos DJ, Gallentine WB, Giza CC, Goldstein JL, Hahn CD, Lerner JT, Loddenkemper T, Matsumoto JH, Nash KB, Payne ET, Sánchez Fernández I, Shults J, Topjian AA, Williams K, Wusthoff CJ, Abend NS.

Seizure. 2015 Feb;25:104-11. doi: 10.1016/j.seizure.2014.09.013. Epub 2014 Oct 5.

17.

Absence of interleukin-1 receptor 1 increases excitatory and inhibitory scaffolding protein expression and microglial activation in the adult mouse hippocampus.

Avdic U, Chugh D, Osman H, Chapman K, Jackson J, Ekdahl CT.

Cell Mol Immunol. 2015 Sep;12(5):645-7. doi: 10.1038/cmi.2014.87. Epub 2014 Sep 29. No abstract available.

18.

The Janus-faced nature of Rasmussen's encephalitis.

Press C, Wallace A, Chapman KE.

Semin Pediatr Neurol. 2014 Jun;21(2):129-36. doi: 10.1016/j.spen.2014.04.018. Epub 2014 Apr 16.

PMID:
25149947
19.

Treatment for continuous spikes and waves during sleep (CSWS): survey on treatment choices in North America.

Sánchez Fernández I, Chapman K, Peters JM, Klehm J, Jackson MC, Berg AT, Loddenkemper T.

Epilepsia. 2014 Jul;55(7):1099-108. doi: 10.1111/epi.12678. Epub 2014 Jun 10.

20.

High-resolution molecular genomic autopsy reveals complex sudden unexpected death in epilepsy risk profile.

Klassen TL, Bomben VC, Patel A, Drabek J, Chen TT, Gu W, Zhang F, Chapman K, Lupski JR, Noebels JL, Goldman AM.

Epilepsia. 2014 Feb;55(2):e6-12. doi: 10.1111/epi.12489. Epub 2013 Dec 24.

Supplemental Content

Loading ...
Support Center